ClinicalTrials.gg

BiologicalDrug

Allogeneic Adipose-derived Mesenchymal Stem Cells clinical trials

studies test it
22
open now
3
in phase 3
2
first study started
2012

Keep track of what changes. Save the Allogeneic Adipose-derived Mesenchymal Stem Cells studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

22 studies that test it; most in 2021 (5)

Studies that test Allogeneic Adipose-derived Mesenchymal Stem Cells, by start year
YearStudies
20122
20141
20153
20161
20181
20191
20204
20215
20221
20231
20242

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
14
Phase 3
2

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 16 · Other 6

Anterogen Co., Ltd. (8) · Sorrento Therapeutics, Inc. (6) · Stempeutics Research Pvt Ltd (2) · Mya Schiess (1) · LaTonya J. Hickson (1) · Rigshospitalet, Denmark (1) · The University of Texas Health Science Center, Houston (1) · Mayo Clinic (1)

Studies

Open first, then newest update. How each study uses Allogeneic Adipose-derived Mesenchymal Stem Cells is read from its arms, and is right about nine times in ten.

Testing it · 22

See all 22 studies that test Allogeneic Adipose-derived Mesenchymal Stem Cells →